B&L launches new stable tubing system

Article

Bausch & Lomb has introduced a stable chamber tubing system, as a part of the new micro incision vacuum pack, to its Millennium Micro Incision Cataract Surgery (MICS) platform.

Bausch & Lomb has introduced a stable chamber tubing system, as a part of the new micro incision vacuum pack, to its Millennium Micro Incision Cataract Surgery (MICS) platform.

As part of the company's ongoing strategy to provide safe and effective 1.8 mm phacoemulsification, the stable chamber tubing system was designed to maintain positive intraocular pressure (IOP) during surgery and to provide surge-free phaco surgery at high vacuums. To achieve this, small diameter tubing is used to create resistance to flow throughout the entire fluidic circuit. A filter is integrated into the aspiration tubing which captures particles larger than 0.5 mm, yet still allows the free flow of fluid, preventing clogging.

Other features of the Millennium MICS platform include the new custom control software which offers five ultrasounding options helping to minimize ?absolute phaco time', reducing heat generation and thus increasing safety.

To support surgeons' transitions to 1.8 mm surgery, Bausch & Lomb has set up the Millennium MICS education programme.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.